Search research articles
Contact Us
Filters
Showing results (271-280 of 309) with videos related to
Page
of 31
Sort By:
British Journal of Cancer
|
February 10, 2024
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy
Hai-Shan Ye, Dan Zhou, Hong Li, et al.
ESMO Open
|
May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
N Epaillard, A Lusque, W Jacot, et al.
Nature Communications
|
January 26, 2026
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice
Jinshan Nan, Huiping Shuai, Jingxin Qiao, et al.
International Journal of Surgery (London, England)
|
November 21, 2023
Artificial intelligence-aided detection for prostate cancer with multimodal routine health check-up data: an Asian multi-center study
Zijian Song, Wei Zhang, Qingchao Jiang, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E Toulemonde, S Chevret, M Battistella, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium
Maria Alice Franzoi, Arlindo R Ferreira, Antoine Lemaire, et al.
Nature Communications
|
January 14, 2023
Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity
Jing Lin, Shihui Sun, Kui Zhao, et al.
Breast (Edinburgh, Scotland)
|
August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives
Leonor Matos, Mette van Ramshorst, Volkmar Müller, et al.
JAMA Network Open
|
April 3, 2024
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer
Jean-Sebastien Frenel, Jean Zeghondy, Catherine Guérin-Charbonnel, et al.
Nature Communications
|
July 30, 2021
BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination
Rania Ghouil, Simona Miron, Lieke Koornneef, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 309) with videos related to
Sort By:
Page
of 31
British Journal of Cancer
|
February 10, 2024
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy
Hai-Shan Ye, Dan Zhou, Hong Li, et al.
ESMO Open
|
May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
N Epaillard, A Lusque, W Jacot, et al.
Nature Communications
|
January 26, 2026
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice
Jinshan Nan, Huiping Shuai, Jingxin Qiao, et al.
International Journal of Surgery (London, England)
|
November 21, 2023
Artificial intelligence-aided detection for prostate cancer with multimodal routine health check-up data: an Asian multi-center study
Zijian Song, Wei Zhang, Qingchao Jiang, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E Toulemonde, S Chevret, M Battistella, et al.
The Lancet Regional Health. Europe
|
October 24, 2024
Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium
Maria Alice Franzoi, Arlindo R Ferreira, Antoine Lemaire, et al.
Nature Communications
|
January 14, 2023
Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity
Jing Lin, Shihui Sun, Kui Zhao, et al.
Breast (Edinburgh, Scotland)
|
August 23, 2025
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives
Leonor Matos, Mette van Ramshorst, Volkmar Müller, et al.
JAMA Network Open
|
April 3, 2024
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer
Jean-Sebastien Frenel, Jean Zeghondy, Catherine Guérin-Charbonnel, et al.
Nature Communications
|
July 30, 2021
BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination
Rania Ghouil, Simona Miron, Lieke Koornneef, et al.
Page
of 31